Literature DB >> 16670065

Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.

Klaus Willenbrock1, Ralf Küppers, Christoph Renné, Verena Brune, Susan Eckerle, Eckhart Weidmann, Andreas Bräuninger, Martin-Leo Hansmann.   

Abstract

BACKGROUND AND OBJECTIVES: Anaplastic large cell lymphoma (ALCL) and classical Hodgkin's lymphoma (HL) are derived from different cell types, namely T cells and B cells, respectively. However, both lymphomas share a similar cytological and immunohistochemical tumor cell phenotype with little resemblance to their cells of origin. DESIGN AND METHODS: In this study, the transcriptional profiles of ALCL cell lines, primary ALCL tumor cells from peripheral blood and HL cell lines were compared to each other and to normal B-cell subsets, B non-Hodgkin's lymphomas (NHL) and B NHL- and Epstein-Barr virus (EBV)-transformed B-cell lines in order to establish their relationship at the transcriptional level and to identify genes with possible pathobiological impact. Expression of some of the genes identified was confirmed in microdissected primary tumor cells by reverse transcriptase polymerase chain reaction (RT-PCR) and immunohistochemistry.
RESULTS: HL samples clustered separately from ALCL samples, but HL and ALCL were found to be more closely related to each other than to any normal or malignant B-cell sample in the dataset. Their relationship was determined to a large extent, but not exclusively, by lack of expression of B-cell antigens and by the over-expression of mRNA encoding activation markers and structural proteins. Apart from established differences between HL and ALCL, further genes of interest could be identified that distinguish both entities from each other and from the other samples. The differential expression of PRAME, DDR2, SOCS3 and CEBPD in HL and ALCL was confirmed in primary tumor tissue by immunohistochemistry and/or RT-PCR. INTERPRETATION AND
CONCLUSIONS: At a transcriptional level HL is more closely related to Alk+ ALCL than to the B-NHL or B-cell samples investigated, although it is a B-cell derived lymphoma. The newly identified genes discriminating HL and ALCL may be pathobiologically important and may serve as possible therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16670065

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  23 in total

1.  Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes.

Authors:  Roberto Piva; Elisa Pellegrino; Michela Mattioli; Luca Agnelli; Luigia Lombardi; Francesco Boccalatte; Giulia Costa; Bruce A Ruggeri; Mangeng Cheng; Roberto Chiarle; Giorgio Palestro; Antonino Neri; Giorgio Inghirami
Journal:  J Clin Invest       Date:  2006-11-16       Impact factor: 14.808

2.  PRAME expression in hairy cell leukemia.

Authors:  Evgeny Arons; Tara Suntum; Inger Margulies; Constance Yuan; Maryalice Stetler-Stevenson; Robert J Kreitman
Journal:  Leuk Res       Date:  2008-03-04       Impact factor: 3.156

3.  Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma.

Authors:  Franziska C Eberle; Joo Y Song; Liqiang Xi; Mark Raffeld; Nancy Lee Harris; Wyndham H Wilson; Stefania Pittaluga; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2012-05       Impact factor: 6.394

Review 4.  Discoidin domain receptor tyrosine kinases: new players in cancer progression.

Authors:  Rajeshwari R Valiathan; Marta Marco; Birgit Leitinger; Celina G Kleer; Rafael Fridman
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

5.  Elevated expression of NFE2L3 predicts the poor prognosis of pancreatic cancer patients.

Authors:  Hui Wang; Ming Zhan; Ruimeng Yang; Yongheng Shi; Qiang Liu; Jian Wang
Journal:  Cell Cycle       Date:  2018-09-22       Impact factor: 4.534

6.  Self-antigen recognition by follicular lymphoma B-cell receptors.

Authors:  Kacey L Sachen; Michael J Strohman; Jonathan Singletary; Ash A Alizadeh; Nicole H Kattah; Chen Lossos; Elizabeth D Mellins; Shoshana Levy; Ronald Levy
Journal:  Blood       Date:  2012-09-28       Impact factor: 22.113

7.  Discoidin domain receptor 1: New star in cancer-targeted therapy and its complex role in breast carcinoma.

Authors:  Hui Jing; Jingyuan Song; Junnian Zheng
Journal:  Oncol Lett       Date:  2018-01-15       Impact factor: 2.967

Review 8.  The biology of Hodgkin's lymphoma.

Authors:  Ralf Küppers
Journal:  Nat Rev Cancer       Date:  2008-12-11       Impact factor: 60.716

9.  Expression of p63 in anaplastic large cell lymphoma but not in classical Hodgkin's lymphoma.

Authors:  Gabriela Gualco; Lawrence M Weiss; Carlos E Bacchi
Journal:  Hum Pathol       Date:  2008-07-11       Impact factor: 3.466

10.  Analysis of human T-cell lymphotropic virus in CD25+ anaplastic large cell lymphoma in children.

Authors:  Gabriela Gualco; Lucimara Chioato; Lawrence M Weiss; William J Harrington; Carlos E Bacchi
Journal:  Am J Clin Pathol       Date:  2009-07       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.